Effect of therapeutic plasma exchange on the anti–factor Xa activity of enoxaparin: A case report
Enoxaparin's anti-factor Xa activity should be monitored and dosing schedules should be adjusted to ensure therapeutic enoxaparin levels in all patients receiving TPE.
Authors
- Thaddaus Hellwig
- Dawood Shehzad (ORCID: https://orcid.org/0009-0001-1412-5328)
- Mamoon Ahmed
- Bri Jansma Vant Hul
- Michaela Schaar
Institutions
- Sanford USD Medical Center (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1093/ajhp/zxag004
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00